ARCA biopharma, Inc. Announces Commencement of Trading on the NASDAQ Global Market Under the Symbol 'ABIO'.
Business Wire › January 28, 2009
Linked as:
Extract
ARCA biopharma, Inc. Announces Commencement of Trading on the NASDAQ Global Market Under the Symbol 'ABIO'.
Experienced Cardiovascular Team Developing the First Genetically-Targeted Treatment for Heart Failure
BROOMFIELD, Colo. -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, announced that on January 28, 2009, its common st...See the full content of this document
Sponsored links
